STE
STERIS plc
NYSE · IEHealthcareMedical - Devices
$214.47-1.55%
Price as of Jul 20, 2026
STE financials
STERIS plc financial statements
Annual and quarterly income statement, balance sheet and cash-flow history. On small screens, start with four periods and expand the table when needed.
| Metric | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | $5.9B | $5.5B | $5.1B | $4.5B |
| Cost of revenue | $3.3B | $3.1B | $2.9B | $2.6B |
| Gross profit | $2.6B | $2.4B | $2.2B | $2.0B |
| Operating expenses | $1.5B | $1.5B | $1.4B | $1.2B |
| Operating income | $1.1B | $866.6M | $836.1M | $791.1M |
| Net income | $785.1M | $614.6M | $378.2M | $107.0M |
| EBITDA | $1.6B | $1.4B | $1.4B | $1.2B |
| Basic EPS | $7.93 | $6.24 | $3.83 | $1.07 |
| Diluted EPS | $7.93 | $6.20 | $3.81 | $1.07 |
| Balance sheet | ||||
| Cash & equivalents | $439.6M | $171.7M | $207.0M | $208.4M |
| Total assets | $10.7B | $10.1B | $11.1B | $10.8B |
| Total liabilities | $3.5B | $3.5B | $4.7B | $4.7B |
| Stockholders’ equity | $7.2B | $6.6B | $6.3B | $6.1B |
| Total debt | $2.1B | $2.2B | $3.4B | $3.2B |
| Net debt | $1.6B | $2.0B | $3.2B | $3.0B |
| Cash flow | ||||
| Operating cash flow | $1.3B | $1.1B | $973.3M | $756.9M |
| Capital expenditure | -$369.0M | -$370.1M | -$360.3M | -$362.0M |
| Free cash flow | $972.4M | $778.0M | $612.9M | $395.0M |
| Dividends paid | -$241.8M | -$219.9M | -$200.6M | -$183.5M |
| Share repurchases | -$235.5M | -$211.3M | -$11.8M | -$308.6M |